Patents by Inventor RICCARDO VINCENZO D'ELIA

RICCARDO VINCENZO D'ELIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses
    Patent number: 11524080
    Abstract: The invention relates to methods for the preparation of a pharmaceutical-vesicle formulation comprising steps of: preparing and processing vesicle components and a pharmaceutical agent to entrap the pharmaceutical agent in the vesicle and form a pharmaceutical-vesicle formulation, wherein the pharmaceutical-vesicle formulation is reconstituted in a known quantity of the pharmaceutical agent dissolved in a pharmaceutically-acceptable carrier to provide a biphasic pharmaceutical-vesicle formulation. The invention also relates to the associated pharmaceutical-vesicle formulations, pharmaceutical kits and uses as a medicament, in particular for the prevention or treatment of infection by bacteria such as Burkholderia pseudomallei and Francisella tularensis, and viruses such as Venezuelan Equine Encephalitis Virus (VEEV).
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: December 13, 2022
    Assignees: The Secretary of State for Defence, The University of Strathclyde
    Inventors: Ethel Diane Williamson, Riccardo Vincenzo D'Elia, Craig William Roberts, Stuart Woods
  • METHODS FOR THE PREPARATION OF A PHARMACEUTICAL-VESICLE FORMULATION AND ASSOCIATED PRODUCTS AND USES
    Publication number: 20210316009
    Abstract: The invention relates to methods for the preparation of a pharmaceutical-vesicle formulation comprising steps of: preparing and processing vesicle components and a pharmaceutical agent to entrap the pharmaceutical agent in the vesicle and form a pharmaceutical-vesicle formulation, wherein the pharmaceutical-vesicle formulation is reconstituted in a known quantity of the pharmaceutical agent dissolved in a pharmaceutically-acceptable carrier to provide a biphasic pharmaceutical-vesicle formulation. The invention also relates to the associated pharmaceutical-vesicle formulations, pharmaceutical kits and uses as a medicament, in particular for the prevention or treatment of infection by bacteria such as Burkholderia pseudomallei and Francisella tularensis, and viruses such as Venezuelan Equine Encephalitis Virus (VEEV).
    Type: Application
    Filed: September 13, 2019
    Publication date: October 14, 2021
    Inventors: ETHEL DIANE WILLIAMSON, RICCARDO VINCENZO D'ELIA, CRAIG WILLIAM ROBERTS, STUART WOODS